The biopharmaceutical market continues to grow at a phenomenal rate, driven by increased demand for biopharmaceutical products that have demonstrated the ability to treat previously untreatable diseases. As biopharmaceutical products move from research and development, through clinical trials, to eventual licensure and commercialization there is a need to develop robust assays to analyze and characterize the products to meet the rigorous criteria of regulatory agencies. Many pharmaceutical and biotech organizations are finding that outsourcing analytical assay development and testing is more cost effective than in-house development, ensures a high level of scientific expertise, and can expedite successful filings with regulatory agencies. Therefore, finding the right contract research organization (CRO) partner to assist in assay development, method validation, and routine analysis can be critical to meeting often aggressive timelines. This infographic looks at a number of points to consider when choosing your contract research organization partner.
